IN the course of our work with progesterone and two 19-nor-contraceptives marked pathological changes in the uterus have been noticed. Each of these compounds acts on the uterus somewhat differently from the others. Thus a comparative discussion of these uterine changes offers considerable interest. The interest such a comparative discussion deserves is all the greater as more recently uterine changes induced by contraceptives have been noticed also in women (Charles. 1964) .
Endometriosis of cystic glands
The steroids were administered by subcutaneous implantation of pellets. For details see our preceding papers (Lipschutz, Iglesias, Panesevich and Salinas. 1967a, b) .
In experiments lasting 13 months the toxic action of progesterone (P) on the uterus becomes highly pronounced. The volume of the uterus is greatly increased and the weight may reach 550 mg., i.e. about ten times that of the normal organ (Table I ). The weight of the uterus is certainly rather a vague index of the variiable changes occurring in this organ. However, the figures in Table I show at a glance the toxic action of P and of the two contraceptives, norethindrone and norethynodrel, on the uterus.
With 665 or 900 ,ug./day of P administered during 13 months the outer surface of the uterus is covered with bulb-like formations. These are cystic glands which have penetrated into the muscular layers and finally reached the surface of the uterus. This kind of endometriosis was present in almost all animals receiving 665 or 900 ,ag./day (Table I; Fig. 2 ). In the group with 117 pug./day there was but 1 animal with endometriosis and it did not reach the pattern characteristic of larger quantities of P (compare Fig. 1 and 2) .
When the administration of P was prolonged for 18 months cystic glands and endometriosis arose with smaller quantities of P. As just mentioned endometriosis was present but in 1 out of 10 animals receiving 117 ptg./day of P during 13 months; on the contrary, in experiments with the same quantity of P but lasting 18 months endometriosis was present in almost all the animals of the group. Endometriosis was present in a considerable percentage also of animals receiving only 59 ,tg./day of P during 18 months.
The great increase of incidence of endometriosis with the increase of P per (Lipschutz, 1960 Endometriosis occurred also with the two contraceptives. As summarized in Table I the great increase of uterine weight and endometriosis were present in 20 out of 25 animals receiving an average of but 7'7 ,ug./day of norethindrone (Fig. 3) , and in half of the animals with an average of 5*5 ,ug./day of norethynodrel (Fig. 4) . However, only rarely was the pattern reached which predominates with very large quantities of P as in Fig. 2 . The difference between norethindrone and norethynodrel was striking.
It is well known that endometriosis occurs also under the prolonged influence of oestrogens. But a picture similar to that offered by the uterus under the prolonged influence of P has never been seen with oestrogens. One may wonder how far progesterone and oestrogen have combined in action when producing this extraordinary type of endometriosis. There was indeed the fact that the oestrogenic influence on the vagina was blocked in all the groups with large quantities of P: there were among 33 aged normal animals 43 per cent in oestrous, and not a single animal of the same age in oestrous among 80 animals receiving 59 to 900 #tg./day of P. However, this fact would not allow any conclusion as to antagonizing of other oestrogenic actions, as evidenced by the condition of the endometrial and glandular epithelium: both kept their normal aspect in experiments with P or norethindrone.
The epithelium of the cystic glands may even become very flattened. But this is most probably due to the intraglandular pressure.
Cystic uterine glands have been seen recently also in rabbits treated during 33 months with hydroxyprogesterone caproate (Meissner and Sommers, 1966). 7 Metaplasia of the endometrial and glandular epithelium induced by norethynodrel
We referred to the condition of the endometrial and glandular epithelium in experiments with P and norethindrone which seemingly keep their normal aspect or may become even flattened. With norethynodrel we became acquainted with a new unexpected phenomenon: the metaplasia of both these epithelial structures.
Metaplasia of the epithelium of the endometrium or of the glands or of both was found in 6 out of 24 animals with norethynodrel. A good example is shown in Fig. 5 where both are in metaplasia. In Fig. 6 only the epithelium of the endometrium is in metaplasia whereas the glands are seemingly intact. In Fig. 7 there is a gland in endometriosis which underwent metaplasia.
Neither with P nor with norethindrone was metaplasia induced. This is an other proof of the differential toxic action of the various 19-nor-steroids used as contraceptives. One might be inclined to explain these changes occurring in the endometrial and glandular epithelium by the conversion of 19-norgestagens into oestrogen (Okada, Amatsu, Ishihara and Tokuda, 1064; Paulsen, 1965) . However, the metaplasia as induced with norethynodrel does not lead to keratinisation of the glandular epithelium as seen in animals of the same strain with subtotal castration causing an ovarian-hypophyseal imbalance (Lipschutz, 1960) .
Sarcoma induced by P and norethindrone in the endometrial stroma A tumour of spindle-shaped cells appeared in the endometrial stroma in 1 out of 32 animals receiving during 13 months 117 to 900 ,ug./day of P (Lipschutz, Iglesias, Panasevich and Salinas, 1966) . This animal received 665 ,ug./day of P. Subsequently similar tumours were found in 15 out of the 142 animals having been treated during 18 months with P and having absorbed 18 to 900 ,ug./day (Table II) . There can scarcely be any doubt that these tumours are sarcomata (see Discussion). They are mostly tiny structures (Fig. 8, 9 ). Strangely enough, the largest tumour was found in an animal belonging to the series receiving only 18 ,ug./day (Fig. 10) . But the incidence of these tumours of the endometrial stroma increased greatly with an increasing quantity of P (Table II) . In the group with 665 /,g./day in 3 out of 4 animals with sarcoma there were several of these tumours, sometimes forming a kind of " galaxy " (Fig. 11) .
The sarcoma was found in 7 cases in the vicinity of glands in endometriosis. The " galaxy " in Fig. 11 is in endometriosis. An illustrative picture of this site of the sarcomata is given in Fig. 12 .
The same tumour was also found in 4 out of 25 animals receiving 8 to 16 /,g./day of norethindrone (Fig. 13-15 ). With these quantities of norethindrone incidence of the tumour of the endometrial stroma was almost as great as with 117 to 900 No animal with norethynodrel showed a tumour of the endometrial stroma.
In 8 animals pertaining to the different groups with P there were in the uterine wall also foci of cells different from those of the sarcomata (Table II) . The uteri of 2 of these animals are shown in Fig. 16 and 17. The focus is located preferably between the two muscular layers of the uterine wall but also in the endometrial stroma. Several double foci of this type may also be present (Fig. 16) . These tumours occurred also in 1 animal receiving norethindrone and in 1 animal receiving norethynodrel.
DISCUSSION
The occurrence of uterine tumours induced in mice by progesterone and 19-nor-contraceptives has to be considered as a definite fact. We shall discuss the problem of these experimental uterine tumours, leaving aside the endometriosis of cystic glands, an endometriosis one may call " fantastic " (see Fig. 2 ; see also the results of Meissner and Sommers, 1966 ; in rabbits and their figures 2 and 3).
There is first the sarcoma of the endometrial stroma. The variable size of the cells and the presence of giant cells and likewise the size of the nuclei and nucleoli-all this is in favour of the opinion that this experimental tumour of the endometrial stroma is a sarcoma. Certainly, the tumours vary structurally between fibrosarcoma, spindle-shaped sarcoma, and round-cell sarcoma (Fig. 8  to 15 ). Only in the large tumour of Fig. 10 the fibrous part was predominant.
Similar tumours have been found in women receiving 19-nor-progestational agents (Charles, 1964) . Charles describes them as " fibrous stromal reaction ", " fibroblast-like stromal cells ", " a celular stroma which might be mistaken for endometrial sarcoma ". Comparing the steroid-induced tumours in mice and women one cannot avoid the impression that in the laboratory animal the sarcomatous trend is structurally much more pronounced than in women.
The structural difference of these tumours between women and mice is possibly due to the great difference in the duration of treatment. Our tumours of the endometrial stroma appeared exceptionally, in 1 case only, in a group of 31 animals treated for 13 months with 117 to 900 /sg./day of progesterone; but their incidence increased to 11 out of 55 animals receiving 117 to 900 ,ug./day of progesterone during 18 months. The 18 months of mice correspond to 40 or 45 years in women! These chronological considerations may render more easy the understanding of the difference as to the pathological patterns elicited in the endometrial stroma by contraceptives, in women on one hand, and in our laboratory animals on the other.
As to the foci of cells, which are certainly different from those of the sarcoma originating in the endometrial stroma or around glands in endometriosis, classification is much more difficult than with sarcoma (compare Fig. 16 and 17 with Fig. 8 to 15 ). Glands or degenerated rests of glands are present in the respective foci both of the endometrial stroma (Fig. 16c) and of the space between the two muscular layers (Fig. 17B) . This makes one suppose that these foci, similarly to the sarcoma, belong always to the endometrial stroma. Are they sarcomata in a process of evolution? SUMMARY A variety of pathological changes is elicited in the uterus by the prolonged administration of progesterone and 19-nor-contraceptives.
These pathological changes are: formation of cystic glands; endometriosis, including that of cystic glands and the appearance of the latter on the surface of the uterus; tumours of the endometrial stroma varying structurally between fibrosarcoma and sarcoma; metaplasia of the endometrial and glandular epithelium; foci of cells in the uterine wall possibly on the way to sarcoma.
The pathogenic activity of the steroids examined differs considerably: tumours of the endometrial stroma are produced by progesterone and norethindrone but not by norethynodrel. On the other hand norethynodrel produces metaplasia of the endometrial and glandular epithelium whereas progesterone and norethindrone are devoid of this action.
Results obtained with the prolonged administration of progesterone give evidence that the appearance of the various pathological patterns is fundamentally dependent both on the quantity of the steroid administrated and on the duration of the administration.
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